Mark Munch, Executive Vice President and President of Bruker Nano Inc., filed a Form 4 with the SEC on September 16, 2026, disclosing the exercise of stock options and sale of common stock in Bruker Corp (NASDAQ:BRKR) on September 15, 2026.

Key Highlights

  • Option exercise: Mark Munch exercised 2,000 stock options on September 15, 2026, at an exercise price of $22.19 per share.
  • Share sale: 2,000 shares of common stock were sold at $52.87 per share on September 15, 2026.
  • 10b5-1 plan: According to the filing, the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  • Remaining ownership: Following the transactions, Munch directly held 134,806 shares of common stock.
  • Option origin: The exercised options were granted on October 4, 2016, vesting on the first through fourth anniversaries of that grant date, with an expiration date of October 4, 2026.

Bruker Nano President Reports Option Exercise and Planned Share Sale

According to the Form 4 filed on September 16, 2026, Mark Munch, who serves as Executive Vice President and President of Bruker Nano Inc., reported two transactions in Bruker Corp common stock occurring on September 15, 2026. The filing identifies Munch as an officer of the issuer and indicates the form was filed by one reporting person.

The filing discloses that Munch exercised stock options covering 2,000 shares of common stock at a conversion or exercise price of $22.19 per share, recorded under transaction code "M." This brought his directly held beneficial ownership to 136,806 shares immediately following the exercise. On the same date, 2,000 shares were sold at a price of $52.87 per share under transaction code "S," reducing his directly held position to 134,806 shares.

The filing notes that the options exercised were originally granted on October 4, 2016, and vested on the first, second, third, and fourth anniversaries of that grant date. The expiration date of the option is listed as October 4, 2026. The derivative security carried a reported price of $0 at exercise. The filing also states that the sales "were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person." The form was signed by Michael Simone as Attorney-in-Fact on September 16, 2026.

What Was Disclosed

Mark Munch, an officer of Bruker Corp (NASDAQ:BRKR), disclosed the exercise of 2,000 stock options at $22.19 and the sale of 2,000 shares at $52.87 on September 15, 2026, under a pre-established Rule 10b5-1 trading plan, leaving him with 134,806 directly held shares.